Special Report:
The 2025 Nobel Prizes in Physics and Physiology or Medicine exemplify how fundamental scientific discoveries can transcend their original boundaries to revolutionize entire fields of human knowledge and technological capability. These awards, announced during the International Year of Quantum Science and Technology, celebrate achievements that illuminate the profound interconnectedness between quantum mechanics and biological systems, while demonstrating how seemingly abstract theoretical work can yield transformative practical applications. The Physics laureates revealed that quantum mechanical phenomena, traditionally confined to the microscopic realm, can manifest in macroscopic systems large enough to hold in one’s hand, fundamentally challenging our understanding of where quantum physics meets classical reality.
Simultaneously, the Medicine laureates decoded the sophisticated regulatory mechanisms that prevent our immune system from attacking our own bodies, unveiling nature’s elegant solution to one of biology’s most complex challenges. Together, these discoveries represent pivotal moments in scientific history, marking the centenary of quantum mechanics with breakthroughs that promise to reshape quantum computing, medical treatments, and our fundamental understanding of both physical and biological systems.
Revolutionary Quantum Mechanics on a Human Scale
The Nobel Prize in Physics 2025 is awarded to John Clarke (University of California, Berkeley), Michel H. Devoret (Yale University), and John M. Martinis (University of California, Santa Barbara) for their discovery of macroscopic quantum mechanical tunneling and energy quantization in an electric circuit. Their groundbreaking work in the 1980s demonstrated that quantum mechanical effects could manifest in systems large enough to hold in one’s hand, fundamentally challenging our understanding of where quantum physics meets the classical world.
The Science Behind the Discovery: Their experiments utilized Josephson junctions – superconducting circuits where two superconducting materials are separated by a thin insulating layer. In these circuits, Cooper pairs (electron pairs with opposite spins) can tunnel through the barrier, creating a macroscopic quantum system that behaves as a single particle filling the entire circuit. The team demonstrated that this system could escape from a zero voltage state through quantum tunnelling, with the changed state detected through voltage appearance.
This discovery revealed that quantum mechanical properties can be made concrete on a macroscopic scale, defying the conventional belief that quantum effects only occur at the atomic level. The system exhibited quantized energy levels, meaning it could only absorb or emit specific amounts of energy, following quantum mechanical predictions.
Transformative Applications in Quantum Technology: The laureates’ work has become the foundation for modern quantum computing technologies. Their discoveries enabled the development of superconducting qubits, particularly transmon qubits and flux qubits, which form the backbone of today’s quantum computers. These qubits can exist in superposition states, allowing quantum computers to process information exponentially faster than classical computers.
Current applications include quantum cryptography, quantum sensors, and quantum computers capable of solving complex optimization problems. Companies like IBM, Google, and others have built quantum computers using principles directly derived from this pioneering work. The technology has also enabled the creation of SQUIDs (Superconducting Quantum Interference Devices), which are exceptionally sensitive magnetic field detectors used in medical imaging and geological surveys.
Decoding the Immune System’s Security Guards
The Nobel Prize in Physiology or Medicine 2025 was awarded to Mary E. Brunkow (Institute for Systems Biology), Fred Ramsdell (Sonoma Biotherapeutics), and Shimon Sakaguchi (Osaka University) for their discoveries concerning peripheral immune tolerance. Their work identified regulatory T cells (Tregs) and the crucial FOXP3 gene, revolutionizing our understanding of how the immune system prevents autoimmune diseases.
The Discovery Journey: Shimon Sakaguchi made the first breakthrough in 1995, swimming against the scientific tide when he discovered a new class of T cells characterized by CD4 and CD25 surface proteins. These cells, unlike typical helper T cells that activate immune responses, actually suppress immune system activity. His work challenged the prevailing belief that immune tolerance only occurred through central mechanisms in the thymus.
Mary Brunkow and Fred Ramsdell provided the molecular foundation for this discovery. Working with “scurfy” mice, a strain that developed severe autoimmune diseases, they spent years mapping the genetic cause. After examining twenty potential genes, they finally identified the FOXP3 gene mutation responsible for the mice’s condition. They subsequently discovered that mutations in the human equivalent caused IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X linked syndrome), a rare but severe autoimmune disease in children.
Medical Applications and Future Treatments: This discovery has opened multiple therapeutic avenues. In cancer treatment, researchers have found that tumors attract large numbers of regulatory T cells that protect them from immune attack. Scientists are now developing strategies to temporarily disable these “security guards” around tumors, allowing the immune system to target cancer cells more effectively.
For autoimmune diseases, the opposite approach is being tested, increasing regulatory T cell numbers to calm overactive immune responses. Clinical trials are investigating interleukin-2 therapy to boost Treg populations in conditions like multiple sclerosis, type 1 diabetes, and rheumatoid arthritis.
In transplantation medicine, researchers are developing methods to multiply a patient’s regulatory T cells in laboratories and engineer them with specific “address labels” to protect transplanted organs from rejection. These cellular therapies could revolutionize organ transplantation success rates.
The Convergence of Quantum Physics and Medical Science
The convergence of quantum physics and medical science represents one of the most exciting frontiers in modern research. Quantum computing is already showing promise in drug discovery, where classical computers struggle to simulate molecular interactions due to the vast number of quantum variables involved. By leveraging quantum principles like superposition and entanglement, quantum computers can model these interactions more accurately, potentially accelerating the identification of new therapeutic compounds.
Quantum sensors are revolutionizing medical imaging, offering unprecedented sensitivity for detecting biological processes. Technologies like optically pumped magnetometers and nitrogen vacancy in diamond magnetometers can significantly increase imaging resolution by harnessing quantum effects. These advances enable magnetoencephalography to map the faintest electrical signals when brain cells fire, providing new insights into neurological conditions.
The applications extend beyond diagnostics to treatment optimization. Quantum enhanced Monte Carlo simulations are improving radiation therapy precision by modelling quantum interactions that govern how energy is deposited in biological tissues. This allows for more precise targeting of tumor cells while minimizing damage to surrounding healthy tissue.
India’s Nobel Prize Legacy and Contemporary Challenges
India has produced nine Nobel laureates since 1913, with five holding Indian citizenship at the time of their awards. The list includes Rabindranath Tagore (Literature, 1913), C.V. Raman (Physics, 1930), Mother Teresa (Peace, 1979), Amartya Sen (Economics, 1998), and Kailash Satyarthi (Peace, 2014).
C.V. Raman remains the only Indian working in India to win a Nobel Prize in science, achieving this honour in 1930 for discovering the Raman Effect, the scattering and wavelength change of light passing through transparent materials. His discovery came just two years after the initial observation, making it one of the fastest Nobel recognitions in history.
The 94-Year Science Nobel Drought: India’s failure to produce science Nobel laureates over the past 94 years reflects several systemic challenges. Research and development spending remains critically low at approximately 0.7% of GDP, compared to 2-4% in countries like the United States, China, and South Korea. This underfunding limits laboratory infrastructure, equipment quality, and long-term research sustainability.
Brain drain represents another significant challenge, with India having only 260 scientists per million people compared to over 4,000 in developed countries. Many promising researchers migrate abroad due to bureaucratic red tape, limited career prospects, and inadequate funding. The recent weakening of financial incentives for high performing scientists has exacerbated this trend.
Institutional inefficiencies plague Indian research environments. Simple equipment procurement can take 11 months at premier institutions like IIT Delhi. Tax policies create additional burdens, with ₹150 crore GST notices served to academic institutions. The focus on applied research for immediate socio economic needs, while important, has come at the expense of fundamental research that typically leads to Nobel-level discoveries.
Global Perspective on Nobel Achievement
The United States leads with 423 Nobel Prizes, followed by the United Kingdom (143) and Germany (115). These countries have sustained investment in research infrastructure, international collaborations, and institutional support for long term scientific inquiry. France, despite its smaller population, maintains the highest per capita Nobel success rate, producing laureates at a consistent rate of 0.2 per year per 100 million inhabitants.
Countries like Japan (32 prizes) and Israel (13 prizes) demonstrate that sustained investment in science education and research can yield significant returns. China’s recent emergence, with targeted policies to attract and retain top scientific talent, shows how strategic approaches can rapidly enhance scientific capabilities.
It is very much visible that Addressing India’s Scientific Challenges is getting crucial. Recent initiatives show promise for India’s scientific future. The government has established new institutions like the Indian Institutes of Science Education and Research (IISERs) and schemes like INSPIRE (Innovation in Science Pursuit for Inspired Research). The Anusandhan National Research Foundation and VAIBHAV Fellowship programs aim to strengthen research ecosystems.
Private sector involvement is expanding, with Infosys creating mini Indian Nobel prizes worth ₹5 crore each for different scientific disciplines. There are encouraging signs of brain drain reversal, with improved infrastructure and opportunities attracting Indian scientists back home.
However, fundamental changes remain necessary. India must increase R&D spending to at least 1.5% of GDP, reduce bureaucratic obstacles, and create research environments that reward risk taking and innovative thinking. Strengthening international collaborations and ensuring young scientists have independence early in their careers will be crucial for future Nobel-level achievements.
In a Nutshell
The 2025 Nobel Prizes represent the pinnacle of human scientific achievement, demonstrating how fundamental research can lead to transformative applications. The Physics laureates showed that quantum mechanics operates beyond the microscopic world, enabling the quantum computing revolution. The Medicine laureates revealed how our immune system maintains the delicate balance between protection and self-tolerance, opening new therapeutic frontiers.
For India, these achievements serve as both inspiration and a reminder of the work needed to reclaim its position among the world’s leading scientific nations. While challenges remain significant, from funding constraints to institutional inefficiencies, recent initiatives and growing private sector support provide hope. With sustained commitment to fundamental research, improved institutional frameworks, and strategic talent retention, India can end its 94-year science Nobel drought and contribute meaningfully to humanity’s scientific progress. The discoveries honored in 2025 will undoubtedly continue shaping our technological and medical landscapes for decades to come, while serving as beacons for the type of breakthrough research India must foster to secure its scientific future.
“Science has no borders, and its light belongs to all of humanity.” – Louis Pasteur
About the Author